Annabel Goodwin

3.2k total citations · 1 hit paper
45 papers, 1.1k citations indexed

About

Annabel Goodwin is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Annabel Goodwin has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 25 papers in Genetics and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Annabel Goodwin's work include BRCA gene mutations in cancer (20 papers), PARP inhibition in cancer therapy (16 papers) and Breast Cancer Treatment Studies (13 papers). Annabel Goodwin is often cited by papers focused on BRCA gene mutations in cancer (20 papers), PARP inhibition in cancer therapy (16 papers) and Breast Cancer Treatment Studies (13 papers). Annabel Goodwin collaborates with scholars based in Australia, United States and Italy. Annabel Goodwin's co-authors include Melina L Willson, Sharon Parker, Davina Ghersi, Nicholas Wilcken, Nicholas Wilcken, Martin R. Stockler, Matthew H. Wong, Nick Pavlakis, Brent O’Carrigan and Jane Beith and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Cochrane Database of Systematic Reviews.

In The Last Decade

Annabel Goodwin

42 papers receiving 1.1k citations

Hit Papers

Talazoparib versus chemotherapy in patients with germline... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial
    2020 252 citations Jennifer K. Litton, Sara A. Hurvitz et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annabel Goodwin Australia 18 722 396 330 281 256 45 1.1k
Sebastian M. Jud Germany 21 442 0.6× 596 1.5× 350 1.1× 141 0.5× 323 1.3× 90 1.4k
Keren Sturtz United States 11 618 0.9× 438 1.1× 268 0.8× 285 1.0× 103 0.4× 18 971
Henrik Hellborg Sweden 18 667 0.9× 355 0.9× 293 0.9× 116 0.4× 337 1.3× 24 1.2k
Miguel Ángel Seguí Spain 22 889 1.2× 444 1.1× 228 0.7× 115 0.4× 267 1.0× 83 1.4k
Nicla La Verde Italy 16 514 0.7× 171 0.4× 127 0.4× 36 0.1× 212 0.8× 64 868
C.-M. Rudenstam Sweden 18 1.2k 1.6× 746 1.9× 304 0.9× 437 1.6× 242 0.9× 28 1.7k
C. Oberhoff Germany 16 454 0.6× 164 0.4× 234 0.7× 30 0.1× 127 0.5× 45 1.1k
Tatsuhiro Shibata Japan 15 551 0.8× 282 0.7× 266 0.8× 70 0.2× 522 2.0× 41 1.4k
Re G Italy 20 823 1.1× 169 0.4× 576 1.7× 35 0.1× 513 2.0× 96 1.6k
Jo Anne Zujewski United States 14 1.1k 1.5× 461 1.2× 233 0.7× 122 0.4× 216 0.8× 23 1.3k

Countries citing papers authored by Annabel Goodwin

Since Specialization
Citations

This map shows the geographic impact of Annabel Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annabel Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annabel Goodwin more than expected).

Fields of papers citing papers by Annabel Goodwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annabel Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annabel Goodwin. The network helps show where Annabel Goodwin may publish in the future.

Co-authorship network of co-authors of Annabel Goodwin

This figure shows the co-authorship network connecting the top 25 collaborators of Annabel Goodwin. A scholar is included among the top collaborators of Annabel Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annabel Goodwin. Annabel Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srinivasa, Sreesha P., Betty Zhang, Annabel Goodwin, et al.. (2025). EP300::VGLL3 rhabdomyosarcoma: a potential distinct indolent adult rhabdomyosarcoma subtype. 2. 100012–100012. 1 indexed citations
2.
3.
4.
Willson, Melina L, et al.. (2024). Platinum chemotherapy for early triple-negative breast cancer. The Breast. 75. 103712–103712. 11 indexed citations
5.
Young, Alison L., et al.. (2023). An Australian mainstream genetic testing program: Clinicians views about current and future practices. Asia-Pacific Journal of Clinical Oncology. 20(1). 119–127. 1 indexed citations
6.
White, Julia, Reena S. Cecchini, Eleanor Harris, et al.. (2023). NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, HR+, HER2-, RS ≤18 breast cancer.. Journal of Clinical Oncology. 41(16_suppl). TPS623–TPS623. 4 indexed citations
7.
Trevena, Lyndal, Bettina Meiser, Llewellyn Mills, et al.. (2022). Which Test Is Best? A Cluster-Randomized Controlled Trial of a Risk Calculator and Recommendations on Colorectal Cancer Screening Behaviour in General Practice. Public Health Genomics. 25(5-6). 193–208.
8.
9.
10.
Beith, Jane, et al.. (2021). Platinum-based chemotherapy for early triple-negative breast cancer. Cochrane Database of Systematic Reviews. 2021(9). 5 indexed citations
11.
Litton, Jennifer K., Sara A. Hurvitz, Lida A. Mina, et al.. (2020). Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial. Annals of Oncology. 31(11). 1526–1535. 252 indexed citations breakdown →
12.
Kiely, Belinda E., Mun N. Hui, Annabel Goodwin, et al.. (2020). CIFeR: A novel Clinician-lead Intervention to address Fear of cancer Recurrence (FCR) in breast cancer survivors.. Journal of Clinical Oncology. 38(15_suppl). 12115–12115. 2 indexed citations
13.
O’Carrigan, Brent, Matthew H. Wong, Melina L Willson, et al.. (2017). Bisphosphonates and other bone agents for breast cancer. Cochrane Database of Systematic Reviews. 2018(11). CD003474–CD003474. 183 indexed citations
14.
Goodwin, Annabel, et al.. (2017). Fulvestrant for hormone-sensitive metastatic breast cancer. Cochrane Database of Systematic Reviews. 2017(1). CD011093–CD011093. 64 indexed citations
15.
Chen, Yanni, Michelle Peate, Rajneesh Kaur, et al.. (2016). Exploring clinicians’ attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer. Familial Cancer. 16(1). 99–109. 6 indexed citations
16.
Ades, Steven, Shailesh Kumar, Murad Alam, et al.. (2015). Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer. Journal of Thrombosis and Haemostasis. 13(6). 998–1003. 63 indexed citations
17.
Robinson, Tracy, Anna Janssen, Judy Kirk, et al.. (2015). New Approaches to Continuing Medical Education: a QStream (spaced education) Program for Research Translation in Ovarian Cancer. Journal of Cancer Education. 32(3). 476–482. 21 indexed citations
18.
Goodwin, Annabel, Sharon Parker, Davina Ghersi, & Nicholas Wilcken. (2009). Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database of Systematic Reviews. CD000563–CD000563. 70 indexed citations
19.
Hussien, Maged, et al.. (2004). Fish-tail plasty: a safe technique to improve cosmesis at the lateral end of mastectomy scars. The Breast. 13(3). 206–209. 15 indexed citations
20.
Nagaratnam, Nages, et al.. (2001). Prolonged abulia following putaminal hemorrhage. Journal of Stroke and Cerebrovascular Diseases. 10(2). 92–93. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian M. Jud Breakdown of academic impact, for papers by Keren Sturtz Breakdown of academic impact, for papers by Henrik Hellborg Breakdown of academic impact, for papers by Miguel Ángel Seguí Breakdown of academic impact, for papers by Nicla La Verde Breakdown of academic impact, for papers by C.-M. Rudenstam Breakdown of academic impact, for papers by C. Oberhoff Breakdown of academic impact, for papers by Tatsuhiro Shibata Breakdown of academic impact, for papers by Re G Breakdown of academic impact, for papers by Jo Anne Zujewski
Rankless by CCL
2026